Jasper Therapeutics is enabling cures through stem cell transplantation. Get information, directions, products, services, phone numbers, and reviews on Jasper Therapeutics in Redwood City, undefined Discover more Pharmaceutical … Jasper Therapeutics Contacts Lily Eng (media) Real Chemistry 206-661-8627 leng@realchemistry.com. Building on niche-clearing technology from Stanford, Dr. Shizuru initiated a clinical program funded by the California Institute for Regenerative Medicine (CIRM) with $23M in grant support to safely condition patients prior to hematopoietic cell transplantation. Get the full list », To view Jasper Therapeutics’s complete executive team members history, request access », To view Jasper Therapeutics’s complete board members history, request access », You’re viewing 5 of 8 investors. There are 2 companies that go by the name of Jasper Therapeutics, Inc.. Biotech firm, Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal with Amplitude Healthcare Acquisition Corp (NASDAQ: AMHC) in … Operator of a biotechnology company intended to expand the application of curative hematopoietic stem cell transplants a, llum dolore eu fugiat nulla pariatur. Jasper is addressing unmet needs in the cancer drugs market by developing a new line of chemotherapy drugs that are effective against the most deadly types of breast, lung, ovarian and pancreatic cancers. Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced positive preliminary findings f Capture Therapeutics by PhysioFirst - Grand Falls Capture Massage Therapists & Dietitians - Grand Falls - Chapel Street Capture Therapeutics Woodstock Capture Therapeutics - Nackawic - Hub Clinic in Town Building . Jasper’s drug pipeline will address unmet needs in breast/lung/ovarian/pancreatic cancer drugs market and multidrug-resistant cancer drugs market. These companies are located in Dover DE and Redwood City CA. Biotech firm, Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal with Amplitude Healthcare Acquisition Corp (NASDAQ: AMHC) in … Company: Jasper Therapeutics, Inc Headquarters Address: 3000 Sand Hill Road B1-145 Menlo Park, CA Main Telephone: 1-650-254-6687 You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Directions & Map | All Locations. Get In Touch. The humanized monoclonal antibody creates a niche space in the bone marrow by safely … Welcome to our online booking site. Jasper Therapeutics, Inc., a new biotechnology company focused on enabling safer conditioning and therapeutic agents that expand the application of curative hematopoietic stem cell transplants and gene therapies, today announced the launch of the company with a $35 million total Series A financing. Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHCU), a special purpose acquisition company (SPAC) sponsored by affiliates of Avego Management, LLC and Metalmark Capital, today announced they have entered into a definitive business combination agreement. Top Investors 2019/2020. REDWOOD CITY, Calif., & NEW YORK– Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHCU), a special purpose acquisition company (SPAC) sponsored by affiliates of Avego Management, LLC and Metalmark Capital, today announced they have entered into a definitive … Biotech firm, Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal with Amplitude Healthcare Acquisition Corp (NASDAQ: AMHC) in a $100 million deal. Jasper Therapeutics Follow Following Location: USA. For more information, please visit us at www.jaspertherapeutics.com. On May 6, 2021, Amplitude Healthcare Corporation, a special purpose acquisition company sponsored by affiliates of Avego Management, LLC and Metalmark Capital, announced that it had entered into a business combination agreement with Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics is a biotechnology company focused on hematopoietic stem cell transplant for a range of indications including hematologic cancers, orphan immunological conditions, non-malignant hematologic conditions and autoimmune diseases. Ideal Therapy specializes in staffing physical therapists, occupational therapists and speech therapists in all types of settings. Jasper Therapeutics’ lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a … Jasper Therapeutics, Inc. is a California Foreign Corporation filed On March 30, 2018. The combined company will be renamed Jasper Therapeutics Inc and its common stock is expected to be listed on NASDAQ under the ticker symbol “JSPR.” Jasper Therapeutics has assembled an exceptional management team of experienced biopharma industry veterans. With this leadership, we are well positioned to achieve our vision of revolutionizing hematopoietic cell transplantation with safer conditioning regimens. Our History. Business profile for Jasper Therapeutics in Jasper, Texas. Jeet Mahal (investors) Jasper Therapeutics 650-549-1403 jmahal@jaspertherapeutics.com. The Registered Agent on file for this company is Jeet Mahal and is located at 2200 Bridge Parkway Suite 102, Redwood City, CA 94065. Location: USA. Jasper Therapeutics’ lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant. Get the full list », Executive Vice President, Research & Development, Co-Founder & Vice President Operations & Program Management. Data Dashboards . The company's filing status is listed as Active and its File Number is C4136097. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell Jasper therapeutics is a drug development company based at the Southampton Science Park. Biotech firm, Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal with Amplitude Healthcare Acquisition Corp (NASDAQ: AMHC) in a $100 million deal. Jasper Therapeutics was founded by Dr. Judith Shizuru, a Stanford professor, and Dr. Susan Prohaska, a Stanford-trained scientist and drug developer, with the goal of bringing curative hematopoietic cell transplantation to more people by making it safer and more effective. Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced that the first patient has been dosed in a multicenter Phase 1 clinical trial of JSP191, a first-in-class humanized monoclonal antibody. Home. Jasper has acquired worldwide rights to JSP 191 from Amgen, which originally discovered JSP191 (formerly AMG 191, as well as translational science and materials from Stanford University. PitchBook is a financial technology company that provides data on the capital markets. Jasper Therapeutics to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference Dec 7, 2020 Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent in Patients with SCID Undergoing Hematopoietic Cell Transplantation For More Press Releases Jasper is a biotechnology company focused on enabling cures with stem cell transplants | Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. © 2021 PitchBook Data. Our novel engineered hematopoietic stem cells (eHSCs) platform is intended to address the limitations of transplant grafts and unlock the potential of stem cells, potentially expanding the number of patients who could benefit from allogeneic and autologous gene edited hematopoietic stem cell therapy. Founded in 2018. The company's lead asset, JSP191, is currently is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation, enabling medical institutions to to safely condition patients with severe combined immunodeficiency. Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic agents. Top CEOs 2019/2020. Explore Jasper Therapeutics Inc's investment information, scientific platforms, therapeutic approaches, indications and more here! JSP191 is an investigational compound that is currently not approved for human use. The company is testing a c-Kit/ CD119 antibody (JSP-191) which is currently in late-stage clinical testing for Hematopoietic Cell Transplantation (HCT) associated with Severe Combined Immunodeficiency and MDS/AML. Jasper Therapeutics $49.10 m in total funding,. If you are interested in joining our team and helping us advance our mission, please email your resume to careers@jaspertherapeutics.com. See insights on Jasper Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Jasper Therapeutics’ management team is comprised of experienced biopharma industry veterans with extensive track records in drug development and commercialization. Our lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation or gene therapy. Copyright © 2021 Jasper Therapeutics, Inc. - All Rights Reserved. Abingworth LLP and Qiming Venture Partners USA served as lead investors, with further investment from Surveyor Capital (a Citadel company), Alexandria Venture Investments, LLC and Roche Venture Fund. Operator of a biotechnology company intended to expand the application of curative hematopoietic stem … PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Infofree.com offers unlimited sales leads, mailing lists, email lists. Operator of a biotechnology company intended to expand the application of curative hematopoietic stem cell transplants and gene therapies. All rights reserved. Jasper unites technologies from Stanford University and Amgen with cutting-edge science and expertise in hematopoietic cell transplantation, stem cell biology, oncology and drug development. Jasper Therapeutics was launched with $50M in Series A financing. Jasper Therapeutics was founded by Dr. Judith Shizuru, a Stanford professor, and Dr. Susan Prohaska, a Stanford-trained immunology and stem cell scientist and drug developer, with the goal of bringing curative hematopoietic cell transplantation and gene therapies to more people by making them safer and more effective. Jasper Therapeutics, Inc. 2200 Bridge Pkwy Suit #102, Redwood City, CA 94065. info@jaspertherapeutics.com (650) 549-1400 Jasper Therapeutics | 1,265 followers on LinkedIn. Sponsored Links. Ideal Therapy Solutions (Therapy Staffing Company) is a Home Health Therapy Management Company in Jasper Texas and surrounding areas. Explore Companies Investors Top 50 Streams Trending tech news Latest investments Latest acquisitions Products Automate Trackers Innovation Services About Index … JASPER THERAPEUTICS, INC. Jasper Therapeutics General Information Description. At Jasper Therapeutics, our goal is to bring curative hematopoietic cell transplantation to more people by making it safer and more effective. Excepteur sint occaecat cupidatat non proident, sunt in culpa, To view Jasper Therapeutics’s complete valuation and funding history, request access », To view Jasper Therapeutics’s complete cap table history, request access », You’re viewing 1 of 1 competitors. Jasper Therapeutics is not responsible for 3rd party website content. JASPER THERAPEUTICS, INC. CALIFORNIA FOREIGN CORPORATION: WRITE REVIEW: Address: 2200 Bridge Parkway, Suite 102 Redwood City, CA 94065: Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. With this leadership, we are well positioned to achieve our vision of exponentially expand the eligible patient population both for allogeneic and autologous gene edited hematopoietic stem cell therapy. Personalize which data points you want to see and create visualizations instantly. Private Company " Jasper is a biotechnology company focused on developing and commercializing safer, more effective conditioning agents to allow for expanded use of curative therapy with stem cell transplantation and gene therapies.